ARTICLE
|
doi:10.20944/preprints202404.1044.v1
Subject:
Oncology And Oncogenics,
Medicine And Pharmacology
Keywords:
Pembrolizumab; Non-small cell lung cancer; real-world data; Immunotherapy; observational study
Online: 16 April 2024 (14:06:32 CEST)
REVIEW
|
doi:10.20944/preprints201903.0256.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
immunocheckpoint inhibitors; chemotherapy; tirosin kinase inhibitors; angiogenesis
Online: 28 March 2019 (06:48:37 CET)